Skip to main content

Deborah A. Daccord

Member

[email protected]

+1.617.348.4716

Follow:
Share:

Deborah is a nationally recognized leader in health industry transactions, with nearly 30 years of experience running complex mergers and acquisitions, joint ventures, strategic alliances, financing and contracting for health care providers and investors across the United States. At any given time, Deborah is engaged in leading teams of the firm’s transactional and regulatory lawyers on several large-scale deals. Her clients value her strategic thinking as well as her project management skills, from both a deal closure and cost perspective. Deborah also provides general counseling and strategic planning for both nonprofit and for-profit health care providers. She is consistently recognized by her peers and leading publications for excellence in health care law.

Deborah’s recent health industry merger and acquisition activity includes acquisitions and sales, joint ventures, and strategic affiliations totaling over one billion dollars. Her clients span the health care spectrum, including providers of ambulatory surgery services, micro-hospital development and management services, physician networks, kidney care services, vision care services, radiology and teleradiology services, home care services, fertility services, value based care, and behavioral health services (including substance use disorder treatment). Deborah has extensive project management experience, and provides deal structuring, general counseling, regulatory advice, and strategic planning for both nonprofit and for-profit health care providers.

Deborah is a Member in the firm's Health Law Practice. She is also a member of the firm's Health Reform Working Group and has served on the Policy Committee.

Deborah is also a certified Pilates instructor.


Deborah is a fantastic attorney and a passionate advocate whose instincts have proven reliable and highly valuable to our team.

- Healthcare Client, Chambers USA 2024

 

Deborah is extraordinarily intelligent and comes forth with very good legal solutions very quickly.

- Healthcare Client, Chambers USA 2024

 

She is smart and very commercial. Deborah gets transactions completed and is thoughtful in her approach.

- Healthcare Client, Chambers USA 2024

Deborah is a nationally recognized leader in health industry transactions, with nearly 30 years of experience running complex mergers and acquisitions, joint ventures, strategic alliances, financing and contracting for health care providers and investors across the United States. At any given time, Deborah is engaged in leading teams of the firm’s transactional and regulatory lawyers on several large-scale deals. Her clients value her strategic thinking as well as her project management skills, from both a deal closure and cost perspective. Deborah also provides general counseling and strategic planning for both nonprofit and for-profit health care providers. She is consistently recognized by her peers and leading publications for excellence in health care law.

Experience

  • Represented a Fortune 500 company that is a leading provider of kidney care services in hundreds of acquisitions, sales, and strategic joint ventures nationwide, including a 50-clinic partial divestiture and strategic joint venture with a leading health system
  • Represented a private equity backed radiology services provider in multiple physician practice and imaging center acquisitions and joint ventures
  • Represented multiple clients in developing value-based care solutions
  • Represented a Northeast regional provider of comprehensive substance use disorder treatment, including acute in-patient, outpatient and long-term residency programs in a cash and roll-over equity sale to a national strategic buyer
  • Represented a provider of geriatric behavioral health services in a cash and roll-over equity sale to a private equity buyer
  • Represented a national provider of physician staffing services in the spin-off and sale of its home health care business and multi-specialty physician practice
  • Represented a leading provider of fertility management services in the development of a cross-border nutraceutical joint venture
Read less

viewpoints

States are increasingly exercising regulatory oversight of health care transactions by enacting laws requiring prior notice or approval of certain health care transactions. Currently, 15 states have enacted health care transaction review laws applicable to for-profit transactions. On Wednesday, March 20, 2024, Mintz members Daniel A. Cody, Deborah A. Daccord, and Karen S. Lovitch engaged in an insightful discussion with Lois Johnson, General Counsel of Massachusetts Health Policy Commission, to discuss the latest developments surrounding these laws and gain valuable insight from Ms. Johnson’s expertise, as Massachusetts was one of the first states to implement a health care transaction review process. The highlights of this informative conversation are summarized below, and the webinar can be viewed here.

Read more

On March 13, 2024, Indiana joined the ranks of states exercising greater oversight and regulation of health care transactions.  Senate Enrolled Act No. 9 (S.B. 9), which takes effect on July 1, 2024, requires written notice to the Indiana Attorney General (the AG) 90 days in advance of an acquisition or merger involving an Indiana “health care entity” that results in a change of control.  The law does not grant the AG authority to approve or deny a transaction, but the AG may evaluate any antitrust concerns and issue a civil investigative demand for additional information. 

Read more

On March 1, 2024, New Mexico joined a growing number of states in enacting legislation that increases oversight of certain health care transactions. Senate Bill 15 (S.B. 15), which adds a new section to the New Mexico Insurance Code (the Code) titled the “Health Care Consolidation Oversight Act” (the Act), takes effect on May 1, 2024.

Read more

California Attorney General Rob Bonta (AG) and Assembly Speaker pro Tempore Jim Wood recently introduced legislation (AB-3129) that would authorize the AG to review private equity group and hedge fund health care transactions. The proposed legislation’s stated intention is to address price increases and lower quality of and decreased accessibility to services associated with private equity acquisitions of certain health care entities, including physician practices. This article provides an overview of the proposed bill, an analysis of the key issues raised by the proposed legislation, and suggestions for next steps for those potentially affected by the proposal. 

Read more

California’s health omnibus trailer bill SB-184 and the final cost and market impact review (CMIR) regulations (CMIR Regulations), which went into effect on December 18, 2023, have ushered in a significant change in California’s health care regulatory landscape with the creation of the Office of Health Care Affordability (OHCA). On January 2, 2024, OHCA began accepting notices of covered transactions through its notice of material change transaction submission portal.

Read more

California’s new Office of Health Care Affordability (OHCA) is set to start pre-closing regulatory review of certain health care transactions on January 1, 2024. As further explained in our previous post, subject to certain exceptions, a broad range of health care entities (collectively, Health Care Entities) soon will be subject to potential pre-closing transaction review.

Read more

California’s new Office of Health Care Affordability (OHCA) is set to begin advance regulatory review of certain health care transactions beginning January 1, 2024. As further explained in our previous post, subject to certain exceptions, a broad range of health care entities (collectively, Health Care Entities) will soon be subject to potential prospective transaction review. OHCA initially published proposed regulations for the new transaction review process in early August (for more details, see our prior post and podcast).  As further discussed in our previous post, these proposed regulations were revised in October and made available on the OHCA website, with a comment period that ended on October 17, 2023. In response to October’s public comments, OHCA has further revised the proposed regulations (Revised Regulations), which are available here. This time however, OHCA has also provided notice of proposed emergency regulatory action, indicating that this version of the regulations will be submitted to the California Office of Administrative Law (OAL) for approval. Once submitted, the public will have five days to provide comments to the OAL. If the OAL approves the regulations, it will file them with the California Secretary of State and the regulations will become effective as emergency regulations for five years as of the filing date. During this period, OHCA will proceed with regular rulemaking action addressing prospective health care transaction review.

Read more

California’s new Office of Health Care Affordability (OHCA) is set to begin advance regulatory review of certain health care transactions beginning January 1, 2024. As further explained in our previous post, subject to certain exceptions, third party payers and administrators, hospitals, hospital systems, fully integrated delivery systems, pharmacy benefit managers, physician organizations, and other providers (collectively, Health Care Entities) will soon be subject to potential prospective transaction review. OHCA initially published proposed regulations for the new transaction review process in early August (for more details, see our prior post and our podcast). Multiple stakeholders expressed concerns with the proposed regulations during the public comment period, which ended August 31, 2023. In response to these comments, OHCA has published revised proposed regulations (Revised Regulations) allowing for an abbreviated comment period that ends October 17, 2023. The Revised Regulations are available here.

Read more
Read less

News & Press

News Thumbnail

Member Deborah Daccord spoke to Modern Healthcare about the state of the market for mental health startups, and what to expect over the next six months.

Press Release Thumbnail

Mintz is pleased to announce that 120 firm attorneys have been recognized as leaders by Best Lawyers® in the 2024 edition of The Best Lawyers in America©.

Press Release Thumbnail

BOSTON –Mintz announced today that 39 of its practices and 81 of its attorneys earned recognition in the 2023 edition of Chambers USA, a guide to the country’s leading law firms.

BOSTON- Mintz is pleased to announce that Member Deborah Daccord has joined CaringBridge’s Board of Directors. Ms. Daccord is among industry leaders in business, technology, health care and the nonprofit sector who support and advise the senior leadership team at CaringBridge in charting the path of the organization in alignment with its mission.

Press Release Thumbnail

Best Lawyers® recognized 108 firm attorneys in the 2023 edition of The Best Lawyers in America©. Notably, two Mintz attorneys – Poonam Patidar and Scott M. Stanton – received 2023 “Lawyer of the Year” awards, and 28 firm attorneys were included in the inaugural edition of Best Lawyers: Ones to Watch.

Press Release Thumbnail
Mintz partner and Massachusetts lawyer Julie Korostoff is one of 49 attorneys recognized as “Leaders in Their Fields” by the 2018 Chambers USA: America's Leading Lawyers for Business guide. Chambers named Korostoff a “Recognized Practitioner” in Technology.
Press Release Thumbnail
Best Lawyers named 85 Mintz attorneys to its 2018 list of The Best Lawyers in America. In addition, Mintz attorneys Matthew J. Gardella and Samuel M. Tony Starr were named “Lawyer of the Year” in their respective practice areas.
Mintz is pleased to announce that Deborah Daccord has been recognized by Massachusetts Lawyers Weekly among the 2017 “Top Women of Law.” Ms. Daccord, a Member in the firm’s Health Law Practice, is also Co-chair of the Health Care Transactions Group.
Best Lawyers named 73 Mintz attorneys to its 2017 list of The Best Lawyers in America. Mintz attorneys selected for inclusion in this year’s list span 44 practice areas. 
Firm’s National Healthcare Practice, NY Corporate/M&A and Litigation: General Commercial Among Newest Rankings
The 2015 Chambers USA: America's Leading Lawyers for Business guide names 52 Mintz, Cohn, Ferris, Glovsky and Popeo, P.C.  attorneys as “Leaders in Their Fields.”
Read less

Events & Speaking

Mar
24
2020

Leading Through a Crisis: COVID-19 Executive Idea Exchange Series

As Companies Working with Senior Populations, How are We Leading?

Webinar

Webinar Reference Image
Panelist
Sep
16
2019

WBL Board Program

Breaking Through to the Boardroom: Advice From Non-Traditional Board Candidates

Chicago, IL

Read less

Deborah is a nationally recognized leader in health industry transactions, with nearly 30 years of experience running complex mergers and acquisitions, joint ventures, strategic alliances, financing and contracting for health care providers and investors across the United States. At any given time, Deborah is engaged in leading teams of the firm’s transactional and regulatory lawyers on several large-scale deals. Her clients value her strategic thinking as well as her project management skills, from both a deal closure and cost perspective. Deborah also provides general counseling and strategic planning for both nonprofit and for-profit health care providers. She is consistently recognized by her peers and leading publications for excellence in health care law.

Recognition & Awards

  • BTI Consulting Group: M&A Client Service All-Star (2021)

  • Featured in Best Lawyers in America: Health Care Law (2012 – 2024)

  • Chambers USA: Massachusetts (Band 1) – Healthcare (2007 – 2018, 2024); (Band 2) - Healthcare (2019 – 2023)

  • Nightingale’s Healthcare News: Outstanding Healthcare Transaction Lawyer (2009)

  • Greater Boston Chamber of Commerce: Boston's Future Leaders (2006)

  • Harvard Law School Irving Oberman Memorial Award

Read less

Deborah is a nationally recognized leader in health industry transactions, with nearly 30 years of experience running complex mergers and acquisitions, joint ventures, strategic alliances, financing and contracting for health care providers and investors across the United States. At any given time, Deborah is engaged in leading teams of the firm’s transactional and regulatory lawyers on several large-scale deals. Her clients value her strategic thinking as well as her project management skills, from both a deal closure and cost perspective. Deborah also provides general counseling and strategic planning for both nonprofit and for-profit health care providers. She is consistently recognized by her peers and leading publications for excellence in health care law.

Involvement

  • Managing Director, Golden Seeds
  • Board of Trustees, Lasell Village
  • President’s Council and Past Board Chair, Big Sister Association of Greater Boston
  • Founding Member, Women for Whittier
  • Member, Women Business Leaders of the U.S. Health Care Industry Foundation
  • Board of Visitors, Fenway Health
  • Member, American Health Lawyers Association
  • Member, Boston Bar Association
  • Member, The Florida Bar
Read less